International Community Must Fund Efforts To Find New TB Vaccines, Drugs, Diagnostics

New York Times: Letter to the Editor: Fighting the Tuberculosis Threat
Thomas G. Evans, CEO of Advancing Tuberculosis Vaccines for the World

“…[T]hroughout the world, nine million people are diagnosed with active TB every year and 1.5 million die — as many people die from HIV. … Decades of neglect have meant that a concerted effort to develop new, more effective TB drugs and vaccines is still playing catch-up to the disease. … The World Health Organization has stated that a new vaccine, as well as new drugs and diagnostics, is critically needed to halt the TB epidemic. Let’s actually fund this effort commensurate to the scale of the problem” (6/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.